BREQUIO (U.S. Trademark Serial Number 87784713) is a United States trademark of Alnylam Pharmaceuticals, Inc.. The goods and services include: Pharmaceutical preparations for the treatment of porphyria The wording “BREQUIO” has no meaning in a foreign language. . The correspondent is Timothy H. Hiebert of Womble Bond Dickinson (US) LLP.
This trademark was filed on February 05, 2018 as United States Trademark Application Serial Number 87784713. This trademark application is still pending and does not yet have a registration number.
Trademark PTO Status History
August 02, 2021 – ABANDONMENT NOTICE E-MAILED – NO USE STATEMENT FILED
August 02, 2021 – ABANDONMENT – NO USE STATEMENT FILED
January 13, 2021 – NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
January 12, 2021 – SOU EXTENSION 5 GRANTED
December 26, 2020 – SOU EXTENSION 5 FILED
January 12, 2021 – CASE ASSIGNED TO INTENT TO USE PARALEGAL
December 26, 2020 – TEAS EXTENSION RECEIVED
June 02, 2020 – NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
View full trademark status information at USPTO
Ownership History
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
View documents on file at USPTO
File a Trademark or Get Help With Trademark Law
Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.